JT
John T. Treace (Chief Executive Officer) filed 5 Form 4 reports in the trailing twelve months (5 purchases, 0 sales), most often in Treace Medical Concepts, Inc. (TMCI). Across 5 priced purchase filings, the average 21-session return was +30.9% from execution and +28.6% from disclosure (delay-adjusted; derived). The largest single filing was $328K of TMCI (111,012 sh across 2 lots, as filed), executed May 27. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+30.9%
avg across 5 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+28.6%
same 5 filings, from disclosure
Filings, ttm
5
5 buys · 0 sells
Median delay
1d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.1M
shares × price, as filed
Last traded
Aug 20
Filed Aug 24
Median ADV $2.9M across their filed names
Impact on $10,000 · 12M
$18,963 (+89.6%)
S&P 500 $10,907 (+9.1%) · 80.6 pts ahead
John T. Treace
S&P 500
Derived: compounded across filings from disclosure dates · past 12 months
Open performance→Volume by month
Buys $1.6M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
5 filings
Sector per market data · by filing · past 12 months
Most traded names
TMCIRecent filings
TMCIPURCHASE
Treace Medical Concepts, Inc.
View filing →
$177K39,944 sh × $4.44
Exec Aug 20
Filed Aug 24 · 5:00 PM ET TMCIPURCHASE Treace Medical Concepts, Inc. View filing → $118K
29,430 sh × $4.02
Exec Jun 10
Filed Jun 11 · 4:52 PM ET TMCIPURCHASE Treace Medical Concepts, Inc. View filing → $178K
50,000 sh × $3.56
Exec Jun 1
Filed Jun 1 · 4:38 PM ET TMCIPURCHASE Treace Medical Concepts, Inc. View filing → $328K
111,012 sh across 2 lots
Exec May 27
Filed May 28 · 4:33 PM ET TMCIPURCHASE Treace Medical Concepts, Inc. View filing → $282K
110,763 sh across 2 lots
Exec May 13
Filed May 14 · 5:33 PM ET TMCIPURCHASE Treace Medical Concepts, Inc. View filing → $524K
60,000 sh × $8.73
Exec Mar 4 2025
Filed Mar 4 2025 · 5:30 PM ET